Bedaquiline loaded lipid nanoparticles: a promising candidate for TB treatment
Ainsa J.A., Codony D., Coya Raboso J.M., Freire C., Hibbitts A., Jary D., Lozano-Fernandez T., Lucia A., Navarro F., Pérez D., Redinger N., Schaible U., Tailleux L., CEA-LETI, FR
Increase in antibiotic resistance is a global concern worldwide[1], with 480,000 new cases of multi-drug resistant tuberculosis (MDR-TB) diagnosed each year. Therefore, the goals for the Nanotherapeutics for Antibiotic Resistant Emmerging Bacterial pathogens (NAREB) research [...]